drugset / Trial / NCT06598943
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The main purpose of this study is to determine the safety and efficacy of eltrekibart and mirikizumab in adult participants with moderately to severely active ulcerative colitis (UC).
Timeline
- Start
- 2024-10-10
- Primary completion
- 2026-08-03
- Completion
- 2027-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eltrekibart | Monoclonal antibody | — | — |
| Subject | Mirikizumab | Monoclonal antibody | — | — |